glp 1 agonist conversion chart Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Comparison of adverse effects between
Description
30.Panuganti KK, Nguyen M, Kshirsagar RK
A small, short study had two patients on liraglutide with positive postprandial C-peptide at baseline completely discontinued insulin treatment with good glycemic control (63)
Additional benefits
2020;131:p
N Engl J Med 2016;375:311322 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Gerstein HC, Colhoun HM, Dagenais GR, et al
Glucagon-like Peptide-1 Receptor Agonists and Risk of Substance Use Disorders among US Veterans with Type 2 Diabetes: Cohort Study. BMJ , vol
